• Home
  • About
  • Contact
  • Issue Archive
  • Special Issues
  • Supplements
Personalized Medicine in Oncology
Subscribe

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Menu
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • NSCLC IO 2022 – Midyear Review
    • Dual IO 2021
    • AACR & ASCO 2021 – Midyear Review
    • ASCO 2020
  • Web Exclusives
    • Rapid Reactions
    • FDA Approvals, News & Updates
    • Press Releases
  • Videos
    • NTRK Gene Fusions
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • PMO Interview with the Innovator Series
  • Conference Correspondent
    • NSCLC IO 2022 – Midyear Review
    • Dual IO 2021
    • AACR & ASCO 2021 – Midyear Review
    • ASCO 2020
  • Web Exclusives
    • Rapid Reactions
    • FDA Approvals, News & Updates
    • Press Releases
  • Videos
    • NTRK Gene Fusions
    • 2018 AONN Midyear
    • 2018 ASCO Insights
    • The Biomarker
  • Home
  • About
  • Contact
  • Issue Archive
  • Special Issues
  • Supplements

Series Three

Fifth Issue Pediatric Cancer Care
Series Three
  • View this Issue
Fourth Issue Impact of the Affordable Care Act on Cancer Care
Series Three
  • View this Issue
Third Issue Advances in Side Effect Management
Series Three
  • View this Issue
Second Issue Access to Care
Series Three
  • View this Issue
First Issue Good Manufacturing Process
Series Three
  • View this Issue
In the News
    May 19, 2016

    Two-pronged attack on chemotherapy-resistant leukemia cells

    May 18, 2016

    An Early Look at Research From the 2016 ASCO Annual Meeting

    May 18, 2016

    Drug against breast cancer is also highly potent against a frequent form of leukaemia

    May 17, 2016

    Improving natural killer cancer therapy: Study

Sign me up!

Copyright 2023. Amplity Medical Communications. All Rights Reserved. Privacy Policy. Sitemap.

By continuing to browse this site, you agree to our use of cookies.